|
|
Blood, 15 February 2006, Vol. 107, No. 4, pp. 1537-1545.
Prepublished online as a Blood First Edition Paper on October 25, 2005; DOI 10.1182/blood-2005-07-2901.
Previous Article | Next Article 
Submitted July 20, 2005
Accepted October 12, 2005
Nitric oxide and cGMP protein kinase (cGK) regulate dendritic cell migration toward the lymph node-directing chemokine CCL19a
Daniela Giordano*, Dario M Magaletti, and Edward A Clark
Department of Immunology, University of Washington, Seattle, WA, USA
Regional Primate Research Center, University of Washington, Seattle, WA, USA
Department of Immunology, University of Washington, Seattle, WA, USA; Regional Primate Research Center, University of Washington, Seattle, WA, USA
* Corresponding author; email: giordano{at}u.washington.edu.
Dendritic cell (DC) migration to secondary lymphoid organs is crucial for the initiation of adaptive immune responses. Although LPS up-regulates CCR7 on DCs, a second signal is required to enable them to migrate toward the chemokine CCL19 (MIP-3 ). We found that the nitric oxide (NO) donor NOR4 provides a signal allowing LPS-stimulated DCs to migrate toward CCL19. NO affects DC migration through both the initial activation of the cGMP/cGK (cGMP kinase) pathway and a long-term effect that reduced cGK activity via negative feedback. Indeed, migration of DCs toward CCL19, unlike migration toward CXCL12 (SDF-1 ), required inhibition of cGK. LPS increased both cGK expression and cGK activity as measured by phosphorylation of the key cGK target VASP (Vasodilator-Stimulated Phosphoprotein). Since cGK phosphorylation of VASP can disrupt focal adhesions and inhibit cell migration, LPS-induced VASP phosphorylation may prevent DCs from migrating without a second signal. Long-term NOR4 treatment inhibited the increase in cGK-dependent VASP phosphorylation, releasing this brake so that DCs can migrate. NO has been implicated in the regulation of autoimmunity through its effect on T cells. Our results suggest that NO regulation of DC migration and cytokine production may contribute to the protective effects of NO in autoimmune disorders.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
R. van de Ven, G. L. Scheffer, A. W. Reurs, J. J. Lindenberg, R. Oerlemans, G. Jansen, J.-P. Gillet, J. N. Glasgow, A. Pereboev, D. T. Curiel, et al.
A role for multidrug resistance protein 4 (MRP4; ABCC4) in human dendritic cell migration
Blood,
September 15, 2008;
112(6):
2353 - 2359.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Ricciardi, A. R. Elia, P. Cappello, M. Puppo, C. Vanni, P. Fardin, A. Eva, D. Munroe, X. Wu, M. Giovarelli, et al.
Transcriptome of Hypoxic Immature Dendritic Cells: Modulation of Chemokine/Receptor Expression
Mol. Cancer Res.,
February 1, 2008;
6(2):
175 - 185.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|